REVERSING IMMUNOTHERAPY RESISTANCE IN OVARIAN CANCER BY TARGETING A NOVEL IMMUNE-SUPPRESSIVE FACTOR RELEASED BY TUMOR-ASSOCIATED MACROPHAGES (TAMS)

Mainehealth, Portland ME

Investigators